Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals

被引:27
|
作者
An, Panpan [1 ]
Li, Jiexin [1 ]
Lu, Linlin [1 ]
Wu, Yingmin [1 ]
Ling, Yuyi [1 ]
Du, Jun [1 ]
Chen, Zhuojia [2 ]
Wang, Hongsheng [1 ]
机构
[1] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangdong Prov Key Lab New Drug Design & Evaluat, Guangzhou 510006, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
TNBC; Migration; HDAC8; YAP; TRANSCRIPTION; HDAC8; PROTEIN;
D O I
10.1016/j.ejphar.2018.12.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Triple-negative breast cancer (TNBC) shows highly aggressive clinical behaviors and poor prognosis compared to other breast cancer subtypes. Histone deacetylases (HDACs) can regulate the progression of various cancers, but the role of HDAC8 in TNBC remains unexplored. Here, we found that HDAC8 enhanced the in vitro migration abilities of breast cancer cells. Targeted inhibition of HDAC8 via si-HDAC8 and its selective inhibitor PCI34051 could suppress the migration of cells. In TNBC cells, HDAC8 stabilized the expression and increased the nuclear localization of YAP, a major downstream effector of Hippo pathway. While silencing YAP could attenuate HDAC8 triggered migration of TNBC cells. Mechanistically, HDAC8 suppressed the phosphorylation of YAP(ser127), which was related to its cytoplasmic sequestration degradation. Our data revealed that HDAC8 could trigger the migration of TNBC cells via regulation of Hippo-YAP signals, suggesting that HDAC8 might be a potential target for TNBC therapy.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 50 条
  • [1] The response of histone deacetylase inhibitors in triple negative breast cancer
    Alzoubi, Madlin
    Nguyen, Khoa
    Burks, Hope
    Hebert, Katherine
    Cheng, Thomas
    Matossian, Margarite
    Wright, Maryl
    Collins-Burow, Bridgette
    Burow, Matthew
    CANCER RESEARCH, 2022, 82 (04)
  • [2] Targeting triple negative breast cancer with histone deacetylase inhibitors
    Fedele, Palma
    Orlando, Laura
    Cinieri, Saverio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (11) : 1199 - 1206
  • [3] Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
    Chandra R Tate
    Lyndsay V Rhodes
    H Chris Segar
    Jennifer L Driver
    F Nell Pounder
    Matthew E Burow
    Bridgette M Collins-Burow
    Breast Cancer Research, 14
  • [4] Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
    Tate, Chandra R.
    Rhodes, Lyndsay V.
    Segar, H. Chris
    Driver, Jennifer L.
    Pounder, F. Nell
    Burow, Matthew E.
    Collins-Burow, Bridgette M.
    BREAST CANCER RESEARCH, 2012, 14 (03)
  • [5] Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells
    Wang, Zhao-Tong
    Chen, Zhuo-Jia
    Jiang, Guan-Min
    Wu, Ying-Min
    Liu, Tao
    Yi, Yan-Mei
    Zeng, Jun
    Du, Jun
    Wang, Hong-Sheng
    CELLULAR SIGNALLING, 2016, 28 (05) : 506 - 515
  • [6] Histone deacetylase inhibitors sensitize cancer stem cells to PARP inhibitors in triple-negative breast cancer
    Liu, Yajing
    Martin-Trevino, Rachel
    Shang, Li
    Davis, April
    Wicha, Max
    Liu, Suling
    Burness, Monika
    CANCER RESEARCH, 2015, 75
  • [7] Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells
    Schech, Amanda
    Kazi, Armina
    Yu, Stephen
    Shah, Preeti
    Sabnis, Gauri
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (08) : 1848 - 1857
  • [8] Regulation of cancer stem cells in triple negative breast cancer
    Fultang, Norman
    Chakraborty, Madhuparna
    Peethambaran, Bela
    CANCER DRUG RESISTANCE, 2021, 4 (02) : 321 - 342
  • [9] Development of a Novel Ferrocenyl Histone Deacetylase Inhibitor for Triple-Negative Breast Cancer Therapy
    Tang, Chu
    Du, Yang
    Liang, Qian
    Cheng, Zhen
    Tian, Jie
    ORGANOMETALLICS, 2018, 37 (14) : 2368 - 2375
  • [10] Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
    Su, Yanrong
    Hopfinger, Nathan R.
    Nguyen, Theresa D.
    Pogash, Thomas J.
    Santucci-Pereira, Julia
    Russo, Jose
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37